The impact of fluid status and renal function on the outcome of patients with heart failure and preserved ejection fraction.

Back

ESC Premium Access

The impact of fluid status and renal function on the outcome of patients with heart failure and preserved ejection fraction.

Session: Poster session 7 - Heart failure / Left ventricular dysfunction

Topic: Prognosis

Speaker: Doctor B. Koell (Hamburg, DE)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Benedikt Koell

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

1 presentation

0 follower

49 more presentations in this session

Survival in HFpEF vs HFrEF patients after beta-blocker titration: new insights from the CIBIS-ELD trial

Speaker: Professor H. Duengen (Berlin, DE)

Access

Abstract

Dual V1a/V2 versus selective V2 vasopressin receptor blockade in a preclinical heart failure model: does it matter?

Speaker: Doctor T. Mondritzki (Wuppertal, DE)

Access

Abstract

Slides

The use of Guideline recommended betablocker therapy in primary prevention ICD patients. Insight from Danish nationwide registries

Speaker: Doctor A. Huth Ruwald (Copenhagen, DK)

Access

Abstract

Slides

The effect of angiotensin II type 2 receptor agonist treatment on doxorubicin induced heart failure

Speaker: Associate Professor N. Ermis (Malatya, TR)

Access

Abstract

Slides

Triiodo-L-thyronine promotes the therapeutic efficacy for myocardial infarction of bone marrow mesenchymal stem cells

Speaker: Professor S. Nie (Beijing, CN)

Access

Abstract

Slides

Access the full session

Poster session 7 - Heart failure / Left ventricular dysfunction

Speakers: Doctor B. Koell, Professor H. Duengen, Doctor T. Mondritzki, Doctor A. Huth Ruwald, Associate Professor N. Ermis...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources